NEVIRAPINE

SynDRA canonical compound SYN0000293 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP3A5
Mechanism of action	Reverse transcriptase inhibitor
Indication	human immunodeficiency virus (HIV-1)
Disease area	infectious disease

All known targets

Non-Nucleoside Reverse Transcriptase Inhibitors
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Cytochrome P450 2B6 Inducers
Cytochrome P450 3A Inducers
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Cytochrome P-450 CYP3A Inducers
Enzyme Inhibitors
Metabolic Side Effects of Drugs and Substances
Nucleic Acid Synthesis Inhibitors

nevirapine hemihydrate
viramune
nevarapine
Nevirapina
Nevirapine teva
Nevirapine, anhydrous
Nevirapinum anhydrous
BIRG-0587
BIRG0587
NSC-641530
Viramune
Viramune xr
Nevirapine anhydrous
NEV
NVP
Cahill May Roberts Brand of Nevirapine
Promeco Brand of Nevirapine
BI-RG-587
BIRG-587
BIRG587
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
Nevirapine & PRO 140
Nevirapine [USAN:INN]
Viramune (TN)
Viramune(TM)
Nevirapine & CD4-IgG
Nevirapine (JAN/USP/INN)
Viramune, BI-RG 587, Nevirapine
BI-RG-587 & CD4-IgG
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
nevirapine anhydrous (usp-rs)
NSC 641530
nevirapine (ep monograph)